Search Results - "McElree, Ian M"

Sequential Intravesical Gemcitabine and Docetaxel for bacillus Calmette-Guérin-Naïve High-Risk Nonmuscle-Invasive Bladder Cancer by McElree, Ian M., Steinberg, Ryan L., Martin, Alex C., Richards, Jordan, Mott, Sarah L., Gellhaus, Paul T., Nepple, Kenneth G., O'Donnell, Michael A., Packiam, Vignesh T.

“…PURPOSEBacillus Calmette-Guérin (BCG) is currently recommended as adjuvant therapy following complete transurethral resection of bladder tumor for high-risk…”
Get full text

Alternative instillation techniques of sequential intravesical gemcitabine and docetaxel for non‐muscle‐invasive bladder cancer by McElree, Ian M., Mott, Sarah L., O'Donnell, Michael A., Packiam, Vignesh T.

Get full text

Long-term follow-up of sequential intravesical gemcitabine and docetaxel salvage therapy for non-muscle invasive bladder cancer by Chevuru, Phani T., McElree, Ian M., Mott, Sarah L., Steinberg, Ryan L., O'Donnell, Michael A., Packiam, Vignesh T.

“…•Long-term outcomes of Gemcitabine/Docetaxel after BCG-failure are not well described.•We retrospectively assessed 97 patients with median follow-up of 49…”
Get full text

The efficacy of sequential intravesical gemcitabine and docetaxel versus BCG for the treatment of European association of urology very-high risk non-muscle invasive bladder cancer by Abou Chakra, Mohamad, Packiam, Vignesh T., McElree, Ian M., Mott, Sarah L., O'Donnell, Michael A.

Get full text

Sequential Intravesical Valrubicin and Docetaxel for the Salvage Treatment of Non-Muscle-Invasive Bladder Cancer by McElree, Ian M, Packiam, Vignesh T, Steinberg, Ryan L, Mott, Sarah L, Gellhaus, Paul T, Nepple, Kenneth G, O'Donnell, Michael A

“…Intravesical gemcitabine-docetaxel has emerged as an efficacious and well-tolerated salvage therapy for non-muscle-invasive bladder cancer. However, further…”
Get full text

Comparison of Sequential Intravesical Gemcitabine and Docetaxel vs Bacillus Calmette-Guérin for the Treatment of Patients With High-Risk Non-Muscle-Invasive Bladder Cancer by McElree, Ian M, Steinberg, Ryan L, Mott, Sarah L, O'Donnell, Michael A, Packiam, Vignesh T

“…Due to the ongoing bacillus Calmette-Guérin (BCG) shortage, sequential intravesical gemcitabine and docetaxel has been increasingly used as first-line therapy…”
Get full text

Early experience with sequential intravesical gemcitabine and docetaxel for micropapillary variant non-muscle invasive bladder cancer by Abou Chakra, Mohamad, McElree, Ian M., Packiam, Vignesh T., Mott, Sarah L., O'Donnell, Michael A.

“…•The management of non-muscle invasive micropapillary urothelial carcinoma (MPUC) is uncertain.•Intravesical Gem/Doce demonstrates similar efficacy in treating…”
Get full text

Sequential endoluminal gemcitabine and docetaxel vs. Bacillus Calmette-Guérin for the treatment of upper tract carcinoma in situ by McElree, Ian M, Mott, Sarah L, Hougen, Helen Y, Packiam, Vignesh T, O'Donnell, Michael A, Steinberg, Ryan L

“…Nephroureterectomy is commonly performed for high-grade (HG) upper tract (UT) urothelial carcinoma (UC). However, some patients may benefit from a…”
Get full text

Sequential endoluminal gemcitabine and docetaxel for the treatment of clinically non-invasive high-grade upper tract urothelial carcinoma by McElree, Ian M, Belzer, Alex, Mott, Sarah L, Packiam, Vignesh T, O'Donnell, Michael A, Steinberg, Ryan L

“…There is an unmet need for effective renal sparing treatments for upper tract urothelial carcinoma (UTUC). Gemcitabine/Docetaxel (Gem/Doce) has shown favorable…”
Get full text

Sequential intravesical gemcitabine and docetaxel for treatment-naïve and previously treated intermediate-risk nonmuscle invasive bladder cancer by McElree, Ian M, Orzel, Joanna, Stubbee, Reid, Steinberg, Ryan L, Mott, Sarah L, O'Donnell, Michael A, Packiam, Vignesh T

“…Adjuvant intravesical therapy is recommended for patients with intermediate-risk NMIBC. While intravesical gemcitabine-docetaxel (Gem/Doce) has demonstrated…”
Get full text

An update on the use of stem cell therapy for erectile dysfunction by Chakra, Mohamad Abou, Bailly, Hugo, Klampke, Fabian, Boaz, Johann, Jida, Mouatasem, Yassine, Ahmad Abou, McElree, Ian M., Moussa, Mohamad

Get full text

Sequential Endoluminal Gemcitabine and Cabazitaxel with Intravenous Pembrolizumab as a Bladder-Preserving Strategy for Docetaxel-Unresponsive Non-Muscle Invasive Urothelial Carcinoma Following Transurethral Resection of Bladder Tumor by McElree, Ian M, Packiam, Vignesh T, Steinberg, Ryan L, Hougen, Helen Y, Mott, Sarah L, Abou Chakra, Mohamad, Zakharia, Yousef, O'Donnell, Michael A

“…Growing evidence suggests that many patients with high-risk non-muscle invasive urothelial carcinoma (NMIUC) can undergo bladder-sparing management with…”
Get full text

Recurrent heterotopic ossification following open radical nephrectomy by Richards, Jordan R., McElree, Ian M., Orzel, Joanna, Smith, Mark C., Packiam, Vignesh T.

“…A 46-year-old male presented with a localized left renal mass and underwent an open radical nephrectomy via a midline incision. He recovered uneventfully and…”
Get full text

Sequential Intravesical Gemcitabine and Docetaxel is an Alternative to Bacillus Calmette-Guérin for the Treatment of Intermediate-risk Non–muscle-invasive Bladder Cancer by Tan, Wei Shen, McElree, Ian M., Davaro, Facundo, Steinberg, Ryan L., Bree, Kelly, Navai, Neema, Dinney, Colin P., O'Donnell, Michael A., Li, Roger, Kamat, Ashish M., Packiam, Vignesh T.

“…Intravesical gemcitabine and docetaxel have comparable efficacy to bacillus Calmette-Guérin in patients with intermediate-risk non–muscle-invasive bladder…”
Get full text

Management of Renal Cell Carcinoma With Supradiaphragmatic Inferior Vena Cava Thrombus Diagnosed During Acute COVID-19 Infection by Leyderman, Michael, McElree, Ian M, Nepple, Kenneth G, Zakharia, Yousef, Ghodoussipour, Saum, Packiam, Vignesh T

“…Renal cell carcinoma (RCC) tends to undergo intravascular tumor growth along the renal vein, forming tumor thrombi that may extend into the inferior vena cava…”
Get full text

Neoadjuvant systemic and intravesical chemotherapy with partial cystectomy for muscle invasive bladder cancer with concomitant CIS by Plambeck, Benjamin D., Tazegul, Tutku E., McElree, Ian M., Steinberg, Ryan L., Packiam, Vignesh T., O'Donnell, Michael A.

“…The presence of carcinoma in situ (CIS) is traditionally a contraindication to bladder-sparing approaches for muscle invasive bladder cancer (MIBC). Strategies…”
Get full text

EDITORIAL COMMENT by Wahlen, Madison M., McElree, Ian M., Packiam, Vignesh T.

Get full text

Sequential endoluminal gemcitabine and docetaxel versus bacillus Calmette–Guérin for the treatment of high-grade upper tract urothelial carcinoma by McElree, Ian M., Mott, Sarah L., Packiam, Vignesh T., O'Donnell, Michael A., Steinberg, Ryan L.

“…613 Background: BCG is currently the only endoluminal treatment option for high-grade (HG) upper tract urothelial carcinoma (UTUC). Gemcitabine/Docetaxel…”
Get full text

MP63-07 SEQUENTIAL ENDOLUMINAL DOXORUBICIN AND GEMCITABINE ALTERNATING WITH SEQUENTIAL MITOMYCIN AND DOCETAXEL FOR MULTI-FAILURE NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE UPPER AND LOWER URINARY TRACTS by Mcelree, Ian M., Steinberg, Ryan L., Sarah L., Packiam, Vignesh T., O'Donnell, Michael A.

Get full text

Sequential intravesical gemcitabine and docetaxel versus bacillus Calmette-Guérin for the treatment of high-risk, treatment-naïve, non-muscle invasive bladder cancer by McElree, Ian M., Steinberg, Ryan L., Mott, Sarah L., O'Donnell, Michael A., Packiam, Vignesh T.

“…497 Background: Due to ongoing bacillus Calmette-Guerin (BCG) shortages, sequential intravesical gemcitabine and docetaxel (Gem/Doce) has been increasingly…”
Get full text